Hans Christian Hagedorn

From WikiMD's Wellness Encyclopedia

Error creating thumbnail:

Hans Christian Hagedorn (6 September 1888 – 6 October 1971) was a Danish physician and biochemist known for his significant contributions to the field of diabetes treatment. He is best known for co-discovering NPH insulin (Neutral Protamine Hagedorn insulin), which became a cornerstone in diabetes management.

Early Life and Education[edit | edit source]

Hans Christian Hagedorn was born in Copenhagen, Denmark. He pursued his medical studies at the University of Copenhagen, where he developed an interest in biochemistry and endocrinology.

Career and Research[edit | edit source]

Hagedorn's career was marked by his dedication to improving the lives of people with diabetes. In 1922, he co-founded the Nordisk Insulinlaboratorium (now part of Novo Nordisk) with August Krogh, a Nobel laureate. This institution was pivotal in the production and distribution of insulin in Europe.

Discovery of NPH Insulin[edit | edit source]

One of Hagedorn's most notable achievements was the development of NPH insulin in 1946. This form of insulin, which combines insulin with the protein protamine, allows for a slower absorption rate, providing more stable blood glucose levels for patients. NPH insulin remains widely used in diabetes treatment today.

Legacy[edit | edit source]

Hagedorn's work has had a lasting impact on the field of diabetes care. The Hagedorn Research Institute, named in his honor, continues to be a leading center for diabetes research. His contributions have improved the quality of life for millions of people with diabetes worldwide.

Personal Life[edit | edit source]

Hagedorn was married and had children. He remained active in his research and professional activities until his death in 1971.

See Also[edit | edit source]

References[edit | edit source]

External Links[edit | edit source]

Contributors: Prab R. Tumpati, MD